The estimated Net Worth of Cynthia L Lucchese is at least $1.75 million dollars as of 1 April 2024. Ms. Lucchese owns over 2,892 units of Hanger Inc stock worth over $92,477 and over the last 19 years she sold HNGR stock worth over $1,433,151. In addition, she makes $225,007 as Independent Director at Hanger Inc.
Cynthia has made over 7 trades of the Hanger Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently she exercised 2,892 units of HNGR stock worth $54,138 on 1 April 2024.
The largest trade she's ever made was exercising 144,347 units of Hanger Inc stock on 19 December 2013 worth over $2,920,140. On average, Cynthia trades about 3,507 units every 70 days since 2005. As of 1 April 2024 she still owns at least 4,940 units of Hanger Inc stock.
You can see the complete history of Ms. Lucchese stock trades at the bottom of the page.
Cynthia L. Lucchese serves as Independent Director of the Company. Ms. Lucchese was Senior Vice President and Chief Financial Officer of Hillenbrand, Inc., where from 2008 to 2014 she was a key member of the leadership team that transformed Hillenbrand from a $650 million North American business to a $1.6 billion global diversified industrial company. She also has extensive experience in the medical device industry, including serving from 2005 to 2007 as Senior Vice President and Chief Financial Officer of Thoratec Corporation, a medical device company focused on treating advanced stage heart failure. Ms. Lucchese also held various senior financial positions with Guidant Corporation, now a part of Boston Scientific Corporation, from 1994 to 2005, including Vice President and Treasurer, Vice President of Finance and Administration - Guidant Sales Corporation, and Vice President - Controller and Chief Accounting Officer. Since July 2014, Ms. Lucchese has served as a member of the Board of Directors, a member of the Nominating & Corporate Governance Committee and Chairman of the Audit Committee of Intersect ENT, Inc. In June 2017, she joined the Board of Directors of Beaver-Visitec, Inc., and serves as Chairman of the Audit Committee. She previously served as a member of the Board of Directors of Brightpoint, Inc. from 2009 to 2012, serving as Chairman of the Audit Committee. In addition, she currently also serves as a member of the Dean’s Council for the Kelley School of Business of Indiana University. Ms. Lucchese, a Certified Public Accountant, earned a bachelor’s degree in accounting and a master’s degree in business administration from Kelley School of Business of Indiana University.
As the Independent Director of Hanger Inc, the total compensation of Cynthia Lucchese at Hanger Inc is $225,007. There are 14 executives at Hanger Inc getting paid more, with Vinit Asar having the highest compensation of $4,940,250.
Cynthia Lucchese is 59, she's been the Independent Director of Hanger Inc since 2015. There are 8 older and 16 younger executives at Hanger Inc. The oldest executive at Hanger Inc is Richard Pettingill, 71, who is the Independent Director.
Cynthia's mailing address filed with the SEC is C/O INARI MEDICAL, INC., 6001 OAK CANYON, IRVINE, CA, 92618.
Over the last 7 years, insiders at Hanger Inc have traded over $2,332,397 worth of Hanger Inc stock and bought 2,700 units worth $51,246 . The most active insiders traders include Thomas C Freyman, Stephen E Hare et Cynthia L Lucchese. On average, Hanger Inc executives and independent directors trade stock every 72 days with the average trade being worth of $339,319. The most recent stock trade was executed by Thomas E Kiraly on 15 March 2022, trading 8,750 units of HNGR stock currently worth $167,650.
About Hanger, Inc.- Hanger, Inc. delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics withapproximately 800locationsnationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With nearly 160 years of clinical excellence and innovation, Hanger's vision is to lead the orthotic and prosthetic markets by providing superior patient care, outcomes, services and value.
Hanger Inc executives and other stock owners filed with the SEC include: